全文获取类型
收费全文 | 2539415篇 |
免费 | 183864篇 |
国内免费 | 3866篇 |
专业分类
耳鼻咽喉 | 35489篇 |
儿科学 | 82979篇 |
妇产科学 | 68327篇 |
基础医学 | 374094篇 |
口腔科学 | 69815篇 |
临床医学 | 225581篇 |
内科学 | 493556篇 |
皮肤病学 | 58165篇 |
神经病学 | 202418篇 |
特种医学 | 96542篇 |
外国民族医学 | 538篇 |
外科学 | 383812篇 |
综合类 | 48773篇 |
现状与发展 | 12篇 |
一般理论 | 900篇 |
预防医学 | 194961篇 |
眼科学 | 59111篇 |
药学 | 189248篇 |
9篇 | |
中国医学 | 4941篇 |
肿瘤学 | 137874篇 |
出版年
2021年 | 20040篇 |
2019年 | 22687篇 |
2018年 | 31662篇 |
2017年 | 23761篇 |
2016年 | 26911篇 |
2015年 | 30162篇 |
2014年 | 41624篇 |
2013年 | 61692篇 |
2012年 | 86373篇 |
2011年 | 90898篇 |
2010年 | 53790篇 |
2009年 | 50412篇 |
2008年 | 84953篇 |
2007年 | 90616篇 |
2006年 | 91386篇 |
2005年 | 89207篇 |
2004年 | 85093篇 |
2003年 | 82000篇 |
2002年 | 79252篇 |
2001年 | 113907篇 |
2000年 | 116502篇 |
1999年 | 97657篇 |
1998年 | 27076篇 |
1997年 | 23363篇 |
1996年 | 23456篇 |
1995年 | 23543篇 |
1994年 | 21633篇 |
1993年 | 20414篇 |
1992年 | 74226篇 |
1991年 | 72429篇 |
1990年 | 70659篇 |
1989年 | 67827篇 |
1988年 | 62198篇 |
1987年 | 61036篇 |
1986年 | 57005篇 |
1985年 | 54713篇 |
1984年 | 40618篇 |
1983年 | 34482篇 |
1982年 | 20577篇 |
1979年 | 37224篇 |
1978年 | 26631篇 |
1977年 | 22064篇 |
1976年 | 21074篇 |
1975年 | 22905篇 |
1974年 | 27321篇 |
1973年 | 25964篇 |
1972年 | 24324篇 |
1971年 | 23103篇 |
1970年 | 21253篇 |
1969年 | 20236篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
31.
Laura A. Huppert MD Ozge Gumusay MD Dame Idossa MD Hope S. Rugo MD 《CA: a cancer journal for clinicians》2023,73(5):480-515
Hormone receptor (HR)-positive and human epidermal growth factor receptor 2 (HER2)-negative breast cancer is defined by the presence of the estrogen receptor and/or the progesterone receptor and the absence of HER2 gene amplification. HR-positive/HER2-negative breast cancer accounts for 65%–70% of all breast cancers, and incidence increases with increasing age. Treatment varies by stage, and endocrine therapy is the mainstay of treatment in both early stage and late-stage disease. Combinations with cyclin-dependent kinase 4/6 inhibitors have reduced distant recurrence in the early stage setting and improved overall survival in the metastatic setting. Chemotherapy is used based on stage and tumor biology in the early stage setting and after endocrine resistance for advanced disease. New therapies, including novel endocrine agents and antibody-drug conjugates, are now changing the treatment landscape. With the availability of new treatment options, it is important to define the optimal sequence of treatment to maximize clinical benefit while minimizing toxicity. In this review, the authors first discuss the pathologic and molecular features of HR-positive/HER2-negative breast cancer and mechanisms of endocrine resistance. Then, they discuss current and emerging therapies for both early stage and metastatic HR-positive/HER2-negative breast cancer, including treatment algorithms based on current data. 相似文献
32.
A. M. Crawford 《Anaesthesia》2023,78(11):1323-1326
33.
- DNA is the sequence that codes for proteins.
- Messenger RNA is transcribed from the DNA sequence of genes and translated into protein.
- It can be difficult to predict how a change in the DNA sequence will affect messenger RNA and protein quantity and quality.
- DNA translocation changes can cause the joining of sequences from two different genes or different parts of the same gene.
- DNA sequencing is often used clinically to predict how DNA changes might affect proteins.
- Alternatively, RNA sequencing can be used as a more direct measure of the effect of DNA changes on the protein products.
- This sequencing is important for identifying changes in cancer that may indicate response to targeted therapy, prognosis, or diagnosis.
34.
Lina Jansen Lars Schwettmann Christian Behr Andrea Eberle Bernd Holleczek Christina Justenhoven Hiltraud Kajüter Kirsi Manz Frederik Peters Ron Pritzkuleit Andrea Schmidt-Pokrzywniak Eunice Sirri Fabian Tetzlaff Sven Voigtländer Volker Arndt 《International journal of cancer. Journal international du cancer》2023,153(10):1784-1796
Age-standardized cancer incidence has decreased over the last years for many cancer sites in developed countries. Whether these trends led to narrowing or widening socioeconomic inequalities in cancer incidence is unknown. Using cancer registry data covering 48 million inhabitants in Germany, the ecological association between age-standardized total and site specific (colorectal, lung, prostate and breast) cancer incidence in 2007 to 2018 and a deprivation index on district level (aggregated to quintiles) was investigated. Incidence in the most and least deprived districts were compared using Poisson models. Average annual percentage changes (AAPCs) and differences in AAPCs between deprivation quintiles were assessed using Joinpoint regression analyses. Age-standardized incidence decreased strongly between 2007 and 2018 for total cancer and all cancer sites (except female lung cancer), irrespective of the level of deprivation. However, differences in the magnitude of trends across deprivation quintiles resulted in increasing inequalities over time for total cancer, colorectal and lung cancer. For total cancer, the incidence rate ratio between the most and least deprived quintile increased from 1.07 (95% confidence interval: 1.01-1.12) to 1.23 (1.12-1.32) in men and from 1.07 (1.01-1.13) to 1.20 (1.14-1.26) in women. Largest inequalities were observed for lung cancer with 82% (men) and 88% (women) higher incidence in the most vs the least deprived regions in 2018. The observed increase in inequalities in cancer incidence is in alignment with trends in inequalities in risk factor prevalence and partly utilization of screening. Intervention programs targeted at socioeconomically deprived and urban regions are highly needed. 相似文献
35.
Knox Joseph A. Kumar Vishal Conrad Miles B. Nanavati Sujal Moore Teri Wilson Mark 《Emergency radiology》2022,29(3):605-609
Emergency Radiology - Access to multi-detector computed tomography (MDCT) scanning for interventional procedures can prove to be logistically challenging as resources are often in different areas... 相似文献
36.
37.
38.
Tsibin A. Yu. Berkovich A. E. Bursian A. A. Ulimbasheva Z. M. Vakhitov M. Sh. 《Biomedical engineering》2022,56(2):124-127
Biomedical Engineering - We present here an experimental study demonstrating the action of noninvasive high-intensity focused ultrasound (HIFU) on vein walls in the treatment of varicose disease.... 相似文献
39.
Kotsyuba A. E. Khramova I. A. Chertok V. M. Romanova T. E. 《Bulletin of experimental biology and medicine》2022,172(3):373-376
Bulletin of Experimental Biology and Medicine - Using the biomicroscopy method, we studied the reaction of arterial and venous vessels of the broad ligament of the uterus in outbred female rats to... 相似文献
40.